Abstract:The global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated scientists to satisfy an urgent need for a rapid and accurate detection of pathogens. Traditionally, the culture-based technique is considered as the gold standard for pathogen detection, yet it has a long turnaround time due to the overnight culturing and pathogen isolation. Alternatively, nucleic acid amplification tests provide a relatively shorter turnaround time to identify whether pathogens exist in individuals with high sensitivity and high specificity. In most cases, nucleic acid amplification tests undergo three steps: sample preparation, nucleic acid amplification, and signal transduction. Despite the explosive advancement in nucleic acid amplification and signal transduction technologies, the complex and labor-intensive sample preparation steps remain a bottleneck to create a transformative integrated point-of-care (POC) molecular diagnostic device. Researchers have attempted to simplify and integrate the sample preparations for nucleic acid-based molecular diagnostic devices with innovative progress in integration strategies, engineered materials, reagent storages, and fluid actuation. Therefore, understanding the know-how and obtaining truthful knowledge of existing integrated POC molecular diagnostic devices comprising sample preparations, nucleic acid amplification, and signal transduction can generate innovative solutions to achieve personalized precision medicine and improve global health.In this Account, we discuss the challenges of automated sample preparation solutions integrated with nucleic acid amplification and signal transduction for rapid and precise home diagnostics. Blood, nasal swab, saliva, urine, and stool are emphasized as the most commonly used clinical samples for integrated POC molecular diagnostics of infectious diseases. Even though these five types of samples possess relatively correlated biomarkers due to the human body's circulatory system, each shows unique properties and exclusive advantages for molecular diagnostics in specific situations, which are included in this Account. We examine different integrated POC devices for sample preparation, which includes pathogen isolation and enrichment from the crude sample and nucleic acid purification from isolated pathogens. We present the promising on-chip integration approaches for nucleic acid amplification. We also investigate the on-chip integration methods for reagent storage, which is crucial to simplify the manual operation for end-users. Finally, we present several integrated POC molecular diagnostic devices for infectious diseases. The integrated sample preparation and nucleic acid amplification approach reviewed here can potentially impact the next generation of POC molecular home diagnostic chips, which will significantly impact public health, emergency medicine, and global biosecurity.

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review

The point-of-care-testing of nucleic acids by chip, cartridge and paper sensors

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing

Emerging Biosensing and Transducing Techniques for Potential Applications in Point-of-care Diagnostics

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example

Application of Nanodiagnostics in Point-of-care Tests for Infectious Diseases

Advances in Nanomaterials and Their Applications in Point of Care (POC) Devices for the Diagnosis of Infectious Diseases.

Advancements in magnetic nanoparticle-based biosensors for point-of-care testing

Advances in Simple, Rapid, and Contamination-Free Instantaneous Nucleic Acid Devices for Pathogen Detection

Advances in DNA/RNA detection using nanotechnology.

Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT)

Integrated Point-of-Care Molecular Diagnostic Devices for Infectious Diseases

The Latest Progress of On-Site Pathogens Detection Techniques and Instruments Based on Nucleic Acid

Recent advances of functional nucleic acid-based sensors for point-of-care detection of SARS-CoV-2

Integrated Microfluidic Systems with Sample Preparation and Nucleic Acid Amplification.

Nucleic acid-based electrochemical nanobiosensors.

Electrochemical nucleic acid sensors: Competent pathways for mobile molecular diagnostics

Point-of-care Nucleic Acid Testing with a One-Step Branched-Dna-based Functional Carbon Biosensor

Point-of-care diagnostics for infectious diseases: From methods to devices